MTB Antibiogram Test (TB NGS) by Next Generation Sequencing - Pure Culture
50+ booked in last 3 daysOverview
The "MTB Antibiogram (TB NGS) by Next Generation Sequencing - Pure Culture" test is a cutting-edge diagnostic tool that employs Next Generation Sequencing (NGS) on pure cultures of Mycobacterium tuberculosis (Mtb) to provide a comprehensive analysis of the bacterial genome, specifically focusing on mutations responsible for resistance against anti-tuberculosis drugs. This test's clinical utility is immense as it offers detailed insights into MTB's genetic profile, enabling healthcare professionals to identify specific drug resistance mutations and tailor highly targeted and effective treatment regimens for tuberculosis (TB) patients. By understanding the bacteria's susceptibility or resistance to various anti-TB medications, clinicians can make informed decisions, optimizing patient care and contributing to the global efforts in combating TB effectively. Overall, the MTB Antibiogram (TB NGS) by Next Generation Sequencing holds great promise in advancing TB management, improving treatment outcomes, and combating drug-resistant strains of the disease.
MTB Antibiogram Test (TB NGS) by Next Generation Sequencing - Pure Culture Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the MTB Antibiogram Test (TB NGS) by Next Generation Sequencing - Pure Culture with a clear pricing structure.
The MTB Antibiogram Test (TB NGS) by Next Generation Sequencing - Pure Culture Price in Mumbai is ₹ 8,925 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
This test detects the mutations in Mycobacterium tuberculosis (MTB) that cause resistance to anti-tuberculosis drugs.
• To identify drug-resistant strains of Mycobacterium tuberculosis in patients with TB • To choose the appropriate antibiotics for treating TB and prevent the development of drug-resistant strains • To guide clinicians in adjusting treatment plans for patients who are not responding to standard TB therapy
This test may be recommended if you • have a confirmed diagnosis of tuberculosis, • have a history of previous TB treatment or exposure to drug-resistant strains, • are not responding to standard TB treatment, or • are at high risk of developing drug-resistant TB due to factors such as close contact with an individual with drug-resistant TB or a history of non-compliance with treatment.
Abnormal results may suggest the need for alternative or modified treatment regimens to effectively treat tuberculosis.
During this test, a sample of your sputum or other respiratory specimen will be collected. This sample to the laboratory for analysis.
• Provide accurate information about your clinical history, including previous TB treatment and exposure to drug-resistant strains. • Follow any instructions given by your doctor regarding discontinuing medications that may interfere with the accuracy of the test. • Inform your doctor if you have any specific requirements.
• Acid-fast bacilli (AFB) smear microscopy: This initial test detects the presence of Mycobacterium tuberculosis in sputum or other respiratory samples. • Culture and drug susceptibility testing (DST): This test determines the presence of TB bacteria and their sensitivity to specific antibiotics.
TB NGS or Mycobacterium tuberculosis Next Generation Sequencing
Tuberculosis (TB) is a contagious bacterial infection caused by Mycobacterium tuberculosis. It primarily affects the lungs but can also affect other organs. TB spreads through the air when an infected individual coughs or sneezes. Symptoms include persistent cough, weight loss, fatigue, and fever.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.